Moderna's mRNA flu shot earns FDA approval after rollercoaster review
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
What happened?
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
Story details
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
Why it matters
This story helps build a stronger internal English tech archive around Technology, giving search visitors more reasons to keep browsing the site instead of bouncing after a single headline.